<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05035303</url>
  </required_header>
  <id_info>
    <org_study_id>RC-200310</org_study_id>
    <nct_id>NCT05035303</nct_id>
  </id_info>
  <brief_title>Can Trajectory Nor-epinephrine Infiltration Reduce Blood Loss During Percutaneous Nephrolithotomy (PCNL)?</brief_title>
  <official_title>Can Trajectory Nor-epinephrine Infiltration Reduce Blood Loss During Percutaneous Nephrolithotomy?: A Double-blind Randomized Placebo Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Benha University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      during PCNL; A few milliliters of nor-epinephrine is injected into the intended tract after&#xD;
      puncture of pelvicalyceal system and before its dilatation compared to injection of saline&#xD;
      (placebo). hemoglobin change &amp; blood loss is estimated and will compared.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients of are positioned in lithotomy position and 6 F open tip ureteral catheter is&#xD;
      fixed by cystoscope. Then, A pelvicalyceal system is punctured under ultrasound and/or&#xD;
      fluoroscopic guidance, then a 18 Gauge (G) puncture needle is introduced toward the desired&#xD;
      calyx and a 0.038 inch guide wire is inserted. then 20 G Chiba needle is introduced alongside&#xD;
      the puncture needle for infiltration of the whole tract by either a few milliliters of&#xD;
      nor-epinephrine or saline. then, the tract is dilated over the guide wire, lastly an Amplatz&#xD;
      sheath was inserted.&#xD;
&#xD;
      nephroscope is used for stones disintegration by pneumatic or laser lithotripter . Fragments&#xD;
      are washed out or removed by forceps.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 10, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>double- blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>hemoglobin drop</measure>
    <time_frame>72 hours post intervention</time_frame>
    <description>the lower drop is better</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood loss</measure>
    <time_frame>immediately after surgery</time_frame>
    <description>the lower loss is better</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>stone free rate</measure>
    <time_frame>within 3 months post-operative</time_frame>
    <description>the higher is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>within 30 days post-operative</time_frame>
    <description>the lower is better</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Blood Loss, Surgical</condition>
  <arm_group>
    <arm_group_label>Nor-Epinephrine (NE)-Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The PCNL tract is infiltrated by Nor-Epinephrine before its dilatation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>S-Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The PCNL tract is infiltrated by Normal Saline before its dilatation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nor-Epinephrine injection versus saline during PCNL</intervention_name>
    <description>The PCNL tract is infiltrated by Nor-Epinephrine or Normal Saline before its dilatation.</description>
    <arm_group_label>Nor-Epinephrine (NE)-Group</arm_group_label>
    <arm_group_label>S-Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  renal stones&gt;2 cm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  coagulopathy, congenital anomalies, active Urinary tract infections&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Waleed El-Shaer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of medicine, Banha university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Waleed El-Shaer, M.D</last_name>
    <phone>01015767331</phone>
    <phone_ext>0020</phone_ext>
    <email>waleed_elshaer@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Banha University Hospitals</name>
      <address>
        <city>Banha</city>
        <state>Kalubiaya</state>
        <zip>13518</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Waleed El-Shaer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Banha university hospital</name>
      <address>
        <city>BanhƒÅ</city>
        <state>Qalubia</state>
        <zip>13511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 30, 2021</study_first_submitted>
  <study_first_submitted_qc>August 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>September 5, 2021</last_update_submitted>
  <last_update_submitted_qc>September 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benha University</investigator_affiliation>
    <investigator_full_name>Waleed El-Shaer, MD</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Blood Loss, Surgical</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Norepinephrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

